In this episode of the Futurist Society, host Dr. Awesome converses with Dr. Diana Azzam and Jim Foote, co-founders of First Ascent Biomedical. They discuss the groundbreaking advancements in the future of targeted cancer treatment. Diana, an assistant professor at FIU with a doctorate in biochemistry, and Jim, a CEO with extensive tech industry experience, reveal their platform that shows an 83% improvement for patients with refractory cancer. They explain the concept of precision medicine, repurposing FDA-approved drugs, and the technological innovations that allow them to deliver personalized treatment plans within 10 days. Tune in and learn the potential future transformations in the biotech industry specifically in the future of targeted cancer treatment.
Love the show? Subscribe, rate, review, and share! http://thefuturistsociety.net/
The Futurist Society Podcast